<DOC>
	<DOCNO>NCT00549562</DOCNO>
	<brief_summary>This 8-week , prospective open-label study investigate effectiveness tolerability paliperidone ER adolescent young adult autism . Hypothesis : Paliperidone Er well tolerate efficacious reduce aggression , self-injury , irritability adolescent young adult .</brief_summary>
	<brief_title>Study Paliperidone ER Adolescents Young Adults With Autism</brief_title>
	<detailed_description />
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<criteria>Males female age 12 21 year Tanner Sage III IV ( postpubertal ) Diagnostic Statistical Manual Fourth Edition TextRevised ( DSMIVTR ) diagnosis autism Outpatient Ability swallow pill Antipsychotic medicationfree least 2 week Score 4 Clinical Global Impressions Severity Scale Score 18 high Aberrant Behavior Checklist Irritability Scale Mental age 18 month great base test Subjects must good physical health Asperger 's Disorder , Pervasive Developmental Disorder Not Otherwise Specified ( PDD NOS ) , Rett 's Disorder , childhood disintegrative disorder , schizophrenia , bipolar disorder , Fragile X Syndrome , Tuberous Sclerosis A significant medical condition An active seizure disorder Females pregnant Evidence prior adequate trial paliperidone ER History neuroleptic malignant syndrome Hypersensitivity paliperidone ER</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Autistic Disorder</keyword>
</DOC>